SSNA1
Microtubule nucleation factor SSNA1
Also known as: N14, NA14, SSNA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43805
- Gene
- SSNA1
- Ensembl
- ENSG00000176101
- Chromosome
- 9
- Canonical length
- 119 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Basal body,Cytosol
OverviewNCBI Gene
Enables identical protein binding activity and microtubule binding activity. Involved in axonogenesis; cell division; and microtubule nucleation. Located in several cellular components, including axoneme; microtubule organizing center; and midbody. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
119 residues, UniProt reviewed canonical sequence.
>O43805|SSNA1
1 MTQQGAALQN YNNELVKCIE ELCQKREELC RQIQEEEDEK QRLQNEVRQL TEKLARVNEN
61 LARKIASRNE FDRTIAETEA AYLKILESSQ TLLSVLKREA GNLTKATAPD QKSSGGRDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSNA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 123 nTPM
Expression across tissuesHPA
Tissue
- testis: 123 nTPM
- heart muscle: 82 nTPM
- esophagus: 79 nTPM
- pancreas: 77 nTPM
- skeletal muscle: 76 nTPM
- stomach: 68 nTPM
Single-cell type
- esophageal apical cells: 472 nCPM
- late primary spermatocytes: 426 nCPM
- esophageal suprabasal cells: 358 nCPM
- esophageal basal cells: 293 nCPM
- extravillous trophoblasts: 207 nCPM
- enterocytes: 187 nCPM
Immune cell
- eosinophil: 162 nTPM
- plasmacytoid DC: 147 nTPM
- intermediate monocyte: 144 nTPM
- T-reg: 141 nTPM
- non-classical monocyte: 138 nTPM
- memory B-cell: 119 nTPM
Brain region
- white matter: 42 nTPM
- basal ganglia: 33 nTPM
- thalamus: 33 nTPM
- medulla oblongata: 33 nTPM
- midbrain: 32 nTPM
- pons: 31 nTPM
ReferencesPubMed · IEDB
Publications for SSNA1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
4 publications
- Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome.
2009 · Front Biosci (Landmark Ed) · RCR 0.5 · 17 citations - A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
2016 · Autoimmunity · RCR 0.4 · 8 citations - Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis.
2016 · Clin Exp Rheumatol · RCR 0.2 · 5 citations - Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer.
2025 · Oncol Lett · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.6
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon extension
- axonogenesis
- cell division
- intraciliary transport
- microtubule cytoskeleton organization
- microtubule nucleation
- receptor clustering
- smoothened signaling pathway
- axon arborization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SSNA1 family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SSNA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSNA1 as an antibody target. Whether an autoantibody or antibody against SSNA1 could matter depends on whether native SSNA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSNA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SSNA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...